Literature DB >> 17304231

Act1-ivating IL-17 inflammation.

Christopher A Hunter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17304231     DOI: 10.1038/ni0307-232

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  14 in total

Review 1.  Use of forward genetics to discover novel regulators of NF-kappaB.

Authors:  Tao Lu; George R Stark
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

Review 2.  Genetics of susceptibility and treatment response in psoriatic arthritis.

Authors:  Darren D O'Rielly; Proton Rahman
Journal:  Nat Rev Rheumatol       Date:  2011-11-08       Impact factor: 20.543

3.  TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development.

Authors:  Carlo Perricone; Cinzia Ciccacci; Fulvia Ceccarelli; Davide Di Fusco; Francesca Romana Spinelli; Enrica Cipriano; Giuseppe Novelli; Guido Valesini; Fabrizio Conti; Paola Borgiani
Journal:  Immunogenetics       Date:  2013-07-09       Impact factor: 2.846

4.  Genetics of psoriasis and psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.

Authors:  Proton Rahman; James T Elder
Journal:  J Rheumatol       Date:  2012-02       Impact factor: 4.666

5.  Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2.

Authors:  Eva Ellinghaus; David Ellinghaus; Philip E Stuart; Rajan P Nair; Sophie Debrus; John V Raelson; Majid Belouchi; Hélène Fournier; Claudia Reinhard; Jun Ding; Yun Li; Trilokraj Tejasvi; Johann Gudjonsson; Stefan W Stoll; John J Voorhees; Sylviane Lambert; Stephan Weidinger; Bernadette Eberlein; Manfred Kunz; Proton Rahman; Dafna D Gladman; Christian Gieger; H Erich Wichmann; Tom H Karlsen; Gabriele Mayr; Mario Albrecht; Dieter Kabelitz; Ulrich Mrowietz; Gonçalo R Abecasis; James T Elder; Stefan Schreiber; Michael Weichenthal; Andre Franke
Journal:  Nat Genet       Date:  2010-10-17       Impact factor: 38.330

6.  Delineation of diverse macrophage activation programs in response to intracellular parasites and cytokines.

Authors:  Shuyi Zhang; Charles C Kim; Sajeev Batra; James H McKerrow; P'ng Loke
Journal:  PLoS Negl Trop Dis       Date:  2010-03-30

7.  Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling.

Authors:  Shu Zhu; Wen Pan; Peiqing Shi; Hanchao Gao; Fang Zhao; Xinyang Song; Yan Liu; Lihua Zhao; Xiaoxia Li; Yufang Shi; Youcun Qian
Journal:  J Exp Med       Date:  2010-11-15       Impact factor: 14.307

8.  Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization.

Authors:  Beate Böhm; Harald Burkhardt; Steffen Uebe; Maria Apel; Frank Behrens; André Reis; Ulrike Hüffmeier
Journal:  Arthritis Res Ther       Date:  2012-04-18       Impact factor: 5.156

9.  Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis.

Authors:  Ulrike Hüffmeier; Steffen Uebe; Arif B Ekici; John Bowes; Emiliano Giardina; Eleanor Korendowych; Kristina Juneblad; Maria Apel; Ross McManus; Pauline Ho; Ian N Bruce; Anthony W Ryan; Frank Behrens; Jesús Lascorz; Beate Böhm; Heiko Traupe; Jörg Lohmann; Christian Gieger; Heinz-Erich Wichmann; Christine Herold; Michael Steffens; Lars Klareskog; Thomas F Wienker; Oliver Fitzgerald; Gerd-Marie Alenius; Neil J McHugh; Giuseppe Novelli; Harald Burkhardt; Anne Barton; André Reis
Journal:  Nat Genet       Date:  2010-10-17       Impact factor: 38.330

Review 10.  New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis.

Authors:  Matthew S Doyle; Emily S Collins; Oliver M FitzGerald; Stephen R Pennington
Journal:  Arthritis Res Ther       Date:  2012-10-31       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.